After a year that exposed long-standing inequities in the U.S. healthcare system, healthcare finance leaders are acutely aware of the vulnerabilities facing patient populations. The focus on addressing the social determinants of health and expanding access to historically disadvantaged patients is now more important than ever.
In a recent roundtable discussion, an executive panel...
The COVID-19 pandemic shined a brighter spotlight on health equity and social determinants of health, which motivated healthcare organizations to make greater strides in addressing those issues.
CEOs of hospitals and health systems, especially, have a pivotal role to play in ensuring everyone has fair and equitable access to healthcare. In a recent roundtable discussion, an...
As the revenue cycle of the future becomes more automated, leaders need to think about balancing people, process, and technology. After all, technology is only as good as the data that’s fed into it, and the data is only as good as the people behind it. And those people will have to have a deeper knowledge base than ever before, as their work moves away from rote tasks and toward more complicated problem solving.
As a result of the COVID-19 pandemic, the healthcare innovation landscape has dramatically changed. The global crisis not only gave rise to telehealth, but it also unleashed a new era of innovation, accelerating a multitude of virtual and remote care initiatives, as well as technological solutions that are enabling new models of care. Against this backdrop, healthcare systems are reevaluating the path forward and focusing their resources to better meet the strategic objectives of...
Clinical care is undergoing transformative changes exemplified by the rapid expansion of telehealth services during the coronavirus pandemic. This HealthLeaders Roundtable discussion brought together seven physician leaders to discuss the evolving clinical care landscape.
The discussion covered a range of topics, including:
As hospitals and health systems emerge from the COVID-19 pandemic, there will likely be a fundamental reexamination of care delivery and what consumers expect from the industry. Provider finance executives will be tasked with positioning their organizations for the most sustainable trajectory based on restoring diminished patient volumes and containing costs that ballooned over the past year.
